Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06691451

Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Inflammatory Bowel Diseases Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Intestinal Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

About this study

Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.[1, 2]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age (18yrs - 65yrs) both sex

Exclusion criteria

  • Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Treatment and study plan

Primary outcomes

  1. Comparison between the number of IBD patients with tendency to thrombosis in cases of activity-

    Time frame: Baseline

    -investigate the presence of multiple mutations associated with IBD patients with or without vascular complications.

Study contacts

Contact information is provided by the study sponsor or research team.

Asmaa Mohammed Abdelaal, Master

CONTACT

[email protected]

01066239562 ext. 01066239562

Sponsors and collaborators

Lead sponsor

Asmaa mohammed abdelaal abdelaal

Other

Collaborators

  • Assiut University

Registry information

Official study title

Inherited Thrombophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Nov 15, 2024
Registry last updated
Nov 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.